Domenica Rea
- Molecular Medicine top 5%
-
- Chemotherapy-induced cardiotoxicity and mitigation 15
- Oncology top 5%
- Peptidase Inhibition and Analysis 10
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 4
-
- Cancer, Stress, Anesthesia, and Immune Response 6
-
- Neuropeptides and Animal Physiology 4
Domenica Rea
52 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Medicine 116
- Cardiology and Cardiovascular Medicine 444
- Oncology 519
- Cancer Research 216
- Endocrinology, Diabetes and Metabolism 207
Countries citing papers authored by Domenica Rea
This map shows the geographic impact of Domenica Rea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Domenica Rea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Domenica Rea more than expected).
Fields of papers citing papers by Domenica Rea
This network shows the impact of papers produced by Domenica Rea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Domenica Rea. The network helps show where Domenica Rea may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Domenica Rea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicinbreakdown → | 2021 | 268 |
| 2 | 2020 | 16 | |
| 3 | 2019 | 15 | |
| 4 | 2019 | 9 | |
| 5 | 2018 | 28 | |
| 6 | 2018 | 41 | |
| 7 | 2017 | 10 | |
| 8 | 2017 | 24 | |
| 9 | 2016 | 26 | |
| 10 | 2016 | 11 | |
| 11 | 2015 | 77 | |
| 12 | 2014 | 78 | |
| 13 | 2014 | 34 | |
| 14 | 2013 | 28 | |
| 15 | 2013 | 1 | |
| 16 | 2012 | 62 | |
| 17 | 2012 | 98 | |
| 18 | 2011 | 28 | |
| 19 | 2003 | 2 | |
| 20 | A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy. | 1993 | 6 |
About Domenica Rea
Domenica Rea is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Immunology and Allergy, having authored 52 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (15 papers), Peptidase Inhibition and Analysis (10 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Protease and Inhibitor Mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Neuropeptides and Animal Physiology (4 papers). The work is most often cited by research in Molecular Medicine (116 citations), Cardiology and Cardiovascular Medicine (444 citations) and Oncology (519 citations). Domenica Rea has collaborated with scholars based in Italy, Uruguay and Malaysia. Frequent co-authors include Antônio Barbieri, Claudio Arra, Giuseppe Palma, Antonio Luciano, Nicola Maurea, Sabrina Bimonte, M. Monti, Gerardo Botti, Vincenzo Quagliariello and Claudia De Lorenzo. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.